Abstract
Advances in molecular virology, and in understanding the molecular basis of human disease, has led to intensive efforts to use viruses for delivering therapeutic genes to cells. Although gene therapy (GT) to treat disease is still in its infancy, the techniques developed for gene delivery to cells have become more sophisticated, and are useful in a variety of experimental settings. This chapter focuses on two viral systems: adenovirus (AD) and herpes simplex virus (HSV)-based vectors. AD represents a nonenveloped DNA virus with a well-characterized genome. Vectors have been developed that are reasonably nontoxic and easy to manipulate in the laboratory. HSV vectors are enveloped viruses with a large and well-characterized DNA genome. Nontoxic variants of this virus have also been developed. Although Ad and HSV vectors share some basic features, there are also significant differences in the types of cells that they infect. This chapter focuses on HSV amplicons, which are essentially plasmids packaged into a HSV shell, and on replication-defective Ad.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Further Reading
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C. S., Mastriangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., and Danel, C. (1994), Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat. Genet. 8, 42–51.
Friedmann, T. (1994), Gene therapy for neurological disorders. Trends Genet. 10, 210–214.
Grable, M. and Hearing, P. (1992), Cis and trans requirements for the selective packaging of adenovirus type 5 UNA. J. Tirol. 66, 723–731.
Graham, F. L. (1984), Covalently closed circles of human adenovirus DNA are infectious. EMBO J. 3, 2917–2922.
Graham, F. L. (1987), Growth of 293 cells in suspension culture. J. Gen. Virol. 68, 937–940.
Glorioso, J. C, Deluca, N. A., and Fink, D. J. (1995), Development and application of herpes simplex virus vectors for human gene therapy. Annu. Rev. Microbiol. 49, 675–710.
Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M. L. (1997), Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71, 1842–1849.
Hitt, M., Bett, A. J., Addison, C. L., Prevec, L., and Graham, F. L. (1995), Techniques for human adenovirus vector construction and characterization. Methods Molec. Genet. 7, 13–30.
Horsburgh, B. C., Hubinette, M. M., Qiang, D., MacDonald, M. M. E., and Tufaro F. (1999), Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes. Gene Ther. 6, 922–926.
Zabner, J., Coutre, L. A., Gregory, R. I., Graham, S. M., Smith, A. E., and Welsh, M. J. (1993), Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207–216.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Yeung, S.N., Tufaro, F. (2001). Virus Vectors for Gene Therapy of the Nervous System. In: Fedoroff, S., Richardson, A. (eds) Protocols for Neural Cell Culture. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1385/1-59259-207-4:229
Download citation
DOI: https://doi.org/10.1385/1-59259-207-4:229
Publisher Name: Humana Press
Print ISBN: 978-0-89603-902-5
Online ISBN: 978-1-59259-207-4
eBook Packages: Springer Book Archive